Presentation TCT 2016 When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation. Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor October 31, 2016
Presentation TCT 2016 When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials Presenter: Timothy D. Henry, Amit N. Patel October 31, 2016
Presentation TCT 2016 Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau October 31, 2016
Presentation TCT 2016 Obtaining Informed Consent: The Essentials and How to Succeed in Difficult Scenarios Presenter: David A. Cox, Thomas D. Stuckey, Timothy D. Henry October 30, 2016
Presentation TCT 2015 First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Philippe Menasché October 15, 2015
Presentation TCT 2015 Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns! Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Amit Patel October 15, 2015
Presentation TCT 2015 Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns! Presenter: Francisco Fdez-Aviles, Timothy D. Henry October 15, 2015
Presentation TCT 2015 Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure! Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin October 15, 2015
Presentation TCT 2015 Debate: Are We Really Ready for Phase III Trials? Yes, in STEMI Bone Marrow Mononuclear Fraction Is Ready, and Other Options Are Coming! Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Ricardo Sanz-Ruiz October 15, 2015
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One! Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry October 15, 2015
Presentation TCT 2015 Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How? Presenter: Francisco Fdez-Aviles, Timothy D. Henry October 15, 2015
Presentation TCT 2015 Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link? Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Jay H Traverse October 15, 2015
Presentation TCT 2015 Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Douglas W. Losordo October 15, 2015
Presentation TCT 2015 Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina Presenter: Greg L. Kaluza, Joachim Schofer, Timothy D. Henry October 15, 2015
Presentation TCT 2015 Cell Therapy for CHF Presenter: Henricus J. Duckers, Bernard J. Gersh, Timothy D. Henry October 14, 2015
Presentation TCT 2015 TCTMD Global PCI Mapping Project: Description and Goals Presenter: Timothy D. Henry, Philippe Gabriel Steg, Ivan C. Rokos October 11, 2015
Presentation TCT 2015 Improving Door-in-Door-out in STEMI Transfer: The Last Frontier Presenter: Timothy D. Henry, Philippe Gabriel Steg, Christopher B. Granger October 11, 2015
Presentation TCT 2015 Telemedicine and Artificial Intelligence to Optimize STEMI Outcomes: The Brazil Experience Presenter: Timothy D. Henry, Philippe Gabriel Steg, Roberto Botelho October 11, 2015
Presentation TCT 2015 Is Deferred Stenting an Option? Rationale for the DEFER-STEMI Trial Presenter: Timothy D. Henry, Philippe Gabriel Steg, Colin Berry October 11, 2015
Presentation TCT 2015 A Fresh Look at the Pharmacoinvasive Strategy Presenter: Timothy D. Henry, Philippe Gabriel Steg, Eric R. Bates October 11, 2015